Stocks making the biggest moves midday: Nike, Rent-A-Center, Carnival Cruise


People walk near the entrance to Nike store, May 25, 2022 in Moscow, Russia.

Konstantin Zavrazhin | Getty Images News | Getty Images

Check out the companies making headlines in midday trading.

Nike — Nike shares dropped 12.8% after the sneaker giant said Thursday its inventory was overstocked, up 44% in its latest quarter. As a result it will offer more discounts to clear out the excess merchandise. Other retailers were also dragged down, with Lululemon Athletica and Under Armour losing almost 6% and nearly 5% respectively.

Rent-A-Center — Shares of Rent-A-Center slipped 21.6% after the company slashed its current-quarter earnings guidance, saying that economic conditions have weighed on consumer traffic and payment patterns.

Carnival Cruise — Shares of Carnival Cruise plunged 23.3% after the company forecast a loss for the fourth quarter, saying high fuel prices and inflation will delay its return to profitability. Royal Caribbean and Norwegian Cruise Lines also slipped, falling 13% and 18%, respectively.

Micron — Shares of Micron rose 1.7% after the company reported quarterly earnings that beat Wall Street expectations, even though sales fell. The chipmaker also gave a weaker-than-expected revenue outlook, saying sales are being hit by slowing consumer demand.

Charles River Laboratories — Charles River shares rose 3.6% after Jefferies upgraded the stock to buy from hold, citing the company’s potential in animal studies.

Twitter — Shares of Twitter rose 2.6% after texts between its founder, Jack Dorsey, and Elon Musk were released in court filings. The Tesla CEO is embroiled in a legal battle over his bid to buy the social media company.

Nucor — Shares of steel company Nucor jumped 1.6% after it announced plans to spend $425 million expanding a galvanized steel line at its South Carolina plant.

Amylyx Pharmaceuticals — Shares of the pharmaceutical company dropped 6.8% despite the stock rallying after hours Thursday on news of the Food and Drug Administration approving its controversial Lou Gehrig’s disease drug.

Generac — Shares of Generac gained 2.3% after Cowen initiated coverage of the company with a buy rating. The generator company is a clear industry winner and has value in its solar offering.

— CNBC’s Alex Harring and Michelle Fox contributed reporting.



Source link

Related articles

Bitcoin Normal Creator says Bitcoin Will Turn into ‘Much less Risky’ and Bigger Than Gold

Saifedean Ammous, the writer of the 2018 tutorial e book “The Bitcoin Normal,” mentioned that Bitcoin already capabilities as a medium of alternate and that volatility’s impact on that's prone to diminish.Bitcoin (BTC)...

What are the principle occasions for right now?

EUROPEAN SESSIONWithin the European session, we do not have a lot on the agenda aside from the ultimate Spanish CPI report. The market focuses extra on preliminary knowledge, so the ultimate readings...

HP Shade LaserJet Enterprise 4701 laser printer evaluation

Why you possibly can belief TechRadar We spend hours testing each services or products we evaluation, so that you might be positive you are shopping for the perfect. Discover out extra about how we...

4 Market Realities Distributors Can’t Ignore

This week, I revealed the Purchaser’s Information: Governance, Danger, And Compliance Platforms, 2026, summarizing how happy purchasers are with their governance, danger, and compliance (GRC) platforms. The report is predicated on buyer reference...

Williams Vix Repair Indicator MT5

The Williams Vix Repair Indicator MT5 may help determine these moments by measuring uncommon draw back strain and highlighting intervals when the market could also be reaching an excessive. That drawback issues as a...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com